Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Subscribe To Our Newsletter & Stay Updated
